Associations of proteomic and epigenetic aging clocks with Alzheimer's disease phenotypes: An exploratory analysis
The potential of plasma proteomic clocks in detecting AD‐related phenotypes and co‐morbidities possibly constitute confounding factors, compromising the performance of proteomic aging models is illustrated.